The Faster Clinical Trials Act would create an FDA Center for Clinical Trial Innovation and aims to cut trial costs and enrollment time by at least 30%.
|Articles|October 1, 2006
- Applied Clinical Trials-10-01-2006
- Volume 0
- Issue 0
eShowcase: GlobalView EventNet
System enables IRB members to review ?s in near real-time from anywhere in the world
Advertisement
System enables IRB members to review AEs in near real-time from anywhere in the world
GlobalView EventNet
PPD, Inc. (Wilmington, NC) just released a customizable, global event management and adjudication system for quick review of safety and endpoint-driven data from large clinical trials or registries. The secure, Internet-based system provides broad access to adverse event data, particularly in studies with multiple information sources and ones that need review by a board of independent physicians.
GlobalView EventNet provides access to data in near real-time and allows IRB members to examine the data at their own convenience from any location around the world. The board members can also request follow-up information or confirm adjudicated events through an online interface. GlobalView EventNet also sends automatic email alerts to prompt and encourage timely review. The system electronically compares each IRB member's decision and documents them per established guidelines.
PPD, Inc., (910) 251-0081,
Articles in this issue
about 20 years ago
Impact of EU Directive on Clinical Developmentabout 20 years ago
Assessing Safety in Clinical Trialsabout 20 years ago
eShowcase: eCTDXPress Aspireabout 20 years ago
eShowcase: LabPas CT 2.5about 20 years ago
Informed Consent Considerationsabout 20 years ago
Subject Protection Issues Gain Broad Supportabout 20 years ago
Data Management: R.I.P. or Brave New World?about 20 years ago
Hurricane Katrina: What Have We Learned?about 20 years ago
Broad Introduction to CTsabout 20 years ago
CDISC Standards Energize EDCAdvertisement
Related to this article
Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.
In today’s ACT Brief, we examine how sites can avoid both fear-driven and overly aggressive AI adoption, why community-based research needs sustained financial investment, and why patient access matters more than organizational size.
Pacing obesity trial enrollment, anchoring eligibility to stable real-world therapies, and building site and physician relationships improve retention and data quality more than aggressive recruitment or restrictive exclusion criteria do.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, argues that CROs must act as orchestrators rather than aggregators—and that the real test of any AI ecosystem is whether it reduces sponsor coordination burden or just hands it back to them.
Syneos Health and Optum outline a joint model for trial planning, recruitment and site access, with no financial terms or timelines disclosed.
AstraZeneca and Oracle Outline AI Collaboration for Clinical Trial Recruitment and Safety Monitoring
What sponsors and sites should know about the AstraZeneca-Oracle AI collaboration on trial recruitment, safety monitoring and data governance.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
2
Building Standardized Evidence for eSource-Enabled Clinical Trials: Multi-Site Validation of a Clinical Research Coordinator Satisfaction Methodology
3
Where AI Governance in Clinical Development Falls Short
4
Syneos Health, Optum Partner on Adaptive Clinical Development Model
5